Platelet Reactivity and MES During CEA
NCT01547039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2012-03-12
Summary
The purpose of this study is to analyze the association between aspirin efficacy and general platelet reactivity in relation to microembolic signals (MES) during carotid endarterectomy (CEA).
Conditions
- Carotid Artery Stenosis
- Ischemic Stroke
- Myocardial Infarction
- Aspirin Resistance
Sponsors & Collaborators
-
UMC Utrecht
lead OTHER
Principal Investigators
-
Gert Jan de Borst, MD, PhD · UMC Utrecht
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement
NCT00465218 ·Status: COMPLETED
-
Monitoring Response to Antiplatelet Therapy
NCT00327041 ·Status: UNKNOWN
-
The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery
NCT01432652 ·Status: COMPLETED
-
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913 ·Status: UNKNOWN
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
NCT04295486 ·Status: RECRUITING ·Phase: PHASE2
-
Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery
NCT01174862 ·Status: COMPLETED
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
COMT on Aspirin Platelets Effects (CAPE)
NCT03433586 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery
NCT02209909 ·Status: COMPLETED ·Phase: NA
-
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
NCT02797548 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
NCT00508924 ·Status: COMPLETED ·Phase: PHASE2
-
Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease
NCT01820429 ·Status: COMPLETED
-
Aortic Arch Related Cerebral Hazard Trial (ARCH)
NCT00235248 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Function in Patients With an Acute Coronary Syndrome
NCT01992484 ·Status: UNKNOWN
-
Resistance on Antithrombotic Drugs in Ischemic Heart Disease
NCT00742430 ·Status: COMPLETED
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
NCT00735280 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients
NCT01198379 ·Status: WITHDRAWN ·Phase: PHASE4
-
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
NCT04338919 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient
NCT01045785 ·Status: UNKNOWN
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Impact of Early Surgery and Maintenance of Antiplatelet Therapy on Intraoperative Bleeding and Major Adverse Cardiovascular Event After Percutaneous Coronary Intervention
NCT02941588 ·Status: COMPLETED